Drug and Therapeutics Bulletin 1998;36:80; doi:10.1136/dtb.1998.361080
Copyright © 1998 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Co-proxamol or paracetamol for acute pain?

Relevant BNF section: 4.7.1

Fifteen years ago, we drew attention to the widespread use of the fixed-dose combination product co-proxamol (dextropropoxyphene 32.5mg plus paracetamol 325mg) and the paucity of evidence that it was more effective than paracetamol alone.1 Co-proxamol is still widely used in the UK. Here, we consider its use and review data comparing co-proxamol with paracetamol in the short-term relief of pain.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1998 BMJ Publishing Group Ltd.